1092579-75-3 Usage
Uses
Used in Organic Synthesis:
BCIP is utilized as a reagent in organic synthesis, where its ability to participate in various chemical reactions makes it a valuable building block for the creation of complex molecules. Its structural features and reactivity contribute to the synthesis of a wide range of organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, BCIP is employed as a key component in the development of novel drugs and pharmaceuticals. Its unique structure and chemical properties are harnessed to explore new avenues in drug discovery, potentially leading to the creation of new therapeutic agents.
Used in Medicinal Chemistry:
BCIP's potential applications extend to the field of medicinal chemistry, where its diverse reactivity and structural attributes are leveraged to design and optimize compounds with specific biological activities. This can include the development of new drugs targeting various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1092579-75-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,2,5,7 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1092579-75:
(9*1)+(8*0)+(7*9)+(6*2)+(5*5)+(4*7)+(3*9)+(2*7)+(1*5)=183
183 % 10 = 3
So 1092579-75-3 is a valid CAS Registry Number.
1092579-75-3Relevant academic research and scientific papers
PYRROLO[2,3-B]PYRIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
-
Paragraph 00153; 00166, (2019/03/05)
The present application relates to a compound of Formula I, or a salt, hydrate or solvate thereof, as defined herein. The present compounds are found to have pharmacological effects, particularly at MRCK. Further provided are pharmaceutical compositions comprising said compounds. The present invention also relates to the use of these compounds as therapeutic agents, in particular, for the treatment and/or prevention of proliferative diseases, such as cancer.
